The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)

Employment - Merck Sharp & Dohme

Stock and Other Ownership Interests  - Abbvie; Bristol-Myers Squibb; Johnson & Johnson; Merck Sharp & Dohme

Consulting or Advisory Role - Merck Sharp & Dohme (Inst)

Variation in recurrence rate and overall survival (OS) outcomes by disease stage and incremental impact of time to recurrence on OS in localized renal cell carcinoma (RCC).

Naomi B.  Haas

Consulting or Advisory Role - AVEO; Calithera Biosciences; Eisai; Exelixis; Merck Sharp & Dohme; Pfizer; Roche/Genentech

Expert Testimony - Lilly (I)

Rituparna  Bhattacharya

Employment - Merck; Otsuka (I)

Yan  Song

Consulting or Advisory Role - Merck Sharp & Dohme (Inst)

Jackie  Rogerio

Stock and Other Ownership Interests  - Merck

Patents, Royalties, Other Intellectual Property - Patent pending as a Merck emplyee

Su  Zhang

Consulting or Advisory Role - Merck Sharp & Dohme (Inst)

Christopher  Carley

Consulting or Advisory Role - Merck Sharp & Dohme (Inst)

Annika  Anderson

Consulting or Advisory Role - Merck Sharp & Dohme (Inst)

James  Signorovitch

No Relationships to Disclose

Murali  Sundaram

No Relationships to Disclose